GreenLight Biosciences Holdings, (GRNA) Social Stream
GREENLIGHT BIOSCIENCES HOLDINGS PBC (GRNA) Price Targets From Analysts
Use the tables below to see what analysts covering GREENLIGHT BIOSCIENCES HOLDINGS PBC think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2022-12-08 | 1 | $4 | $4 | $4 | $0.299 | 1237.79% |
2023-05-31 | 1 | $0.3 | $0.3 | $0.3 | $0.299 | 0.33% |
Price Target Last Issued December 8, 2022
GRNA Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
3 | 0 | 0 | 1 | 0 | 0 | 1 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GRNA as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, GREENLIGHT BIOSCIENCES HOLDINGS PBC's number of analysts covering the stock is higher than nearly none of them.
- In terms of how GREENLIGHT BIOSCIENCES HOLDINGS PBC fares relative to all US stocks, note that its variance in analysts' estimates is lower than nearly 100% of that group.
- In terms of how GREENLIGHT BIOSCIENCES HOLDINGS PBC fares relative to Healthcare stocks, note that its average analyst price target is higher than 4.67% of that group.
- In the context of stocks in the small market cap category, GREENLIGHT BIOSCIENCES HOLDINGS PBC's upside potential (average analyst target price relative to current price) is higher than 104.81% of them.
Stocks similar to GREENLIGHT BIOSCIENCES HOLDINGS PBC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are FNCH, IKNA, and IPSC.
View All Top Stocks by Price Target
Make investment decisions regarding GRNA using the data that counts. Try POWR Ratings for free.